Share buybacks · 2011–2025
Ligand Pharmaceuticals share buybacks
$15.0M+$15.0M · FY2025
Ligand Pharmaceuticals (LGND) reported $15.0M in share buybacks for fiscal 2025, +$15.0M from the year before.
| Fiscal year | Share buybacks | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $15.0M | +$15.0M | Open → |
| FY20242024-12-31 | $0 | $0 | Open → |
| FY20232023-12-31 | $0 | $0 | Open → |
| FY20222022-12-31 | $0 | $0 | Open → |
| FY20212021-12-31 | $0 | −100.0% | Open → |
| FY20202020-12-31 | $78.0M | −82.8% | Open → |
| FY20192019-12-31 | $453M | +268.7% | Open → |
| FY20182018-12-31 | $123M | +6,149.6% | Open → |
| FY20172017-12-31 | $2.0M | −49.6% | Open → |
| FY20162016-12-31 | $3.9M | +697.8% | Open → |
| FY20152015-12-31 | $489,000 | −99.3% | Open → |
| FY20142014-12-31 | $68.0M | +$68.0M | Open → |
| FY20132013-12-31 | $0 | $0 | Open → |
| FY20122012-12-31 | $0 | −100.0% | Open → |
| FY20112011-12-31 | $55,000 | — | Open → |
Share buybacks — Share buybacks are the cash a company spent during the year repurchasing its own stock, taken from the financing section of the cash-flow statement. Most companies buy back nothing at all — the line is absent rather than zero — so this ranking covers the minority that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +49.3%
Share buybacks at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ligand Pharmaceuticals share buybacks |url=https://companiesranked.com/en/company/ligand-pharmaceuticals/share-buybacks |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ligand Pharmaceuticals share buybacks. CompaniesRanked. https://companiesranked.com/en/company/ligand-pharmaceuticals/share-buybacksBibTeX
@misc{companiesranked-en-company-ligand-pharmaceuticals-share-buybacks-2026,
author = {{CompaniesRanked}},
title = {{Ligand Pharmaceuticals share buybacks}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ligand-pharmaceuticals/share-buybacks}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000886163-26-000006 · February 27, 2026
{{cite web |title=Ligand Pharmaceuticals share buybacks — 10-K (0000886163-26-000006) |url=https://www.sec.gov/Archives/edgar/data/886163/000088616326000006/lgnd-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-27}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.